Characterization of Corneal Epithelial Changes in Participants Treated With Belantamab Mafodotin
Clinical trial NCT04549363 · TERMINATED
Trial details
- NCT number
- NCT04549363
- Sponsor
- GlaxoSmithKline
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-21
- Primary completion
- 2022-11-21
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.